Epicrispr Biotechnologies, Inc.

Epicrispr Biotechnologies develops medicines using epigenetic gene regulation. Its technology changes how selected genes are expressed without cutting DNA, with programmes aimed at serious diseases that lack adequate treatments.

Appearances: 1
Categories: 1
First seen: 13 September 2026
Latest: 13 September 2026

← All current risers Open source ↗

01/

Appearance history

1 appearance

#11

Funding rounds · September 2026

monthly · 30d window · SEC Form D

All funding rounds editions →

$177m

$177m of $213m target

This page records every appearance of the same entity in the reviewed RiseFinder exports. Rankings keep the original category, period and measurement direction.

Get early signals on the websites, apps, repositories and startups gaining momentum. Join the list for Risefinder email briefings.

Be first to receive the briefing.

Epicrispr Biotechnologies, Inc.

Appearance history

Get email updates